However, TRIP13 mRNA expression showed no significant changes in kidney chromophobe (KICH), pheochromocytoma and paraganglioma (PCPG), skin cutaneous melanoma (SKCM), thyroid carcinoma (THCA), and thymoma (THYM). This evidence concerns the gene TRIP13 and paraganglioma.